Ekso Bionics Holdings Inc (EKSO)
1.34
+0.05
(+3.88%)
USD |
NASDAQ |
May 03, 16:00
1.32
-0.02
(-1.49%)
After-Hours: 18:36
Ekso Bionics Holdings Enterprise Value: 20.54M for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 20.54M |
| May 01, 2024 | 20.27M |
| April 30, 2024 | 19.64M |
| April 29, 2024 | 20.54M |
| April 26, 2024 | 19.82M |
| April 25, 2024 | 20.36M |
| April 24, 2024 | 18.57M |
| April 23, 2024 | 18.21M |
| April 22, 2024 | 20.36M |
| April 19, 2024 | 21.08M |
| April 18, 2024 | 19.11M |
| April 17, 2024 | 20.36M |
| April 16, 2024 | 21.26M |
| April 15, 2024 | 23.22M |
| April 12, 2024 | 22.51M |
| April 11, 2024 | 20.54M |
| April 10, 2024 | 20.00M |
| April 09, 2024 | 21.61M |
| April 08, 2024 | 21.26M |
| April 05, 2024 | 22.87M |
| April 04, 2024 | 23.94M |
| April 03, 2024 | 23.22M |
| April 02, 2024 | 22.69M |
| April 01, 2024 | 21.08M |
| March 28, 2024 | 21.79M |
| Date | Value |
|---|---|
| March 27, 2024 | 22.87M |
| March 26, 2024 | 24.12M |
| March 25, 2024 | 23.40M |
| March 22, 2024 | 23.76M |
| March 21, 2024 | 23.22M |
| March 20, 2024 | 22.33M |
| March 19, 2024 | 21.79M |
| March 18, 2024 | 21.43M |
| March 15, 2024 | 21.08M |
| March 14, 2024 | 21.61M |
| March 13, 2024 | 22.69M |
| March 12, 2024 | 23.40M |
| March 11, 2024 | 22.51M |
| March 08, 2024 | 25.01M |
| March 07, 2024 | 25.73M |
| March 06, 2024 | 24.30M |
| March 05, 2024 | 25.73M |
| March 04, 2024 | 35.04M |
| March 01, 2024 | 33.07M |
| February 29, 2024 | 31.29M |
| February 28, 2024 | 32.54M |
| February 27, 2024 | 32.54M |
| February 26, 2024 | 32.01M |
| February 23, 2024 | 31.65M |
| February 22, 2024 | 31.65M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-13.52M
Minimum
Nov 30 2022
144.06M
Maximum
May 03 2019
21.91M
Average
16.73M
Median
Nov 14 2023
Enterprise Value Benchmarks
| Vicarious Surgical Inc | -39.76M |
| Perspective Therapeutics Inc | 1.008B |
| Xtant Medical Holdings Inc | 128.57M |
| Asensus Surgical Inc | 45.57M |
| Catheter Precision Inc | 0.595M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.214M |
| Revenue (Quarterly) | 4.847M |
| Total Expenses (Quarterly) | 8.296M |
| EPS Diluted (Quarterly) | -0.22 |
| Gross Profit Margin (Quarterly) | 48.88% |
| Profit Margin (Quarterly) | -66.31% |
| Earnings Yield | -82.09% |
| Normalized Earnings Yield | -83.61 |